C12N 5/0605
Cells from extra-embryonic tissues
Official title: {Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly}
C12N5/0605 (Cells from extra-embryonic tissues) appears on 411 US grants and 887 published applications in this corpus.
Search patents in C12N- Granted patents
- 411
- Published applications
- 887
- Assignees
- 317
- Inventors
- 1,107
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 8 |
| 2004 | 0 | 5 |
| 2005 | 0 | 23 |
| 2006 | 4 | 17 |
| 2007 | 4 | 30 |
| 2008 | 3 | 25 |
| 2009 | 8 | 19 |
| 2010 | 6 | 35 |
| 2011 | 14 | 41 |
| 2012 | 15 | 31 |
| 2013 | 18 | 39 |
| 2014 | 31 | 38 |
| 2015 | 31 | 59 |
| 2016 | 26 | 51 |
| 2017 | 26 | 49 |
| 2018 | 22 | 55 |
| 2019 | 36 | 47 |
| 2020 | 27 | 52 |
| 2021 | 23 | 46 |
| 2022 | 21 | 50 |
| 2023 | 22 | 69 |
| 2024 | 24 | 32 |
| 2025 | 19 | 36 |
| 2026 | 20 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of genomic evaluation in livestock29 Sep 2026US 12,747,455 B2Inguran, LLC
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Equine-specific therapeutic compositions and methods of use8 Sep 2026US 12,728,141 B2Equistem Technology, LLC
- Stem cell and tissue cultures and their products11 Aug 2026US 12,703,855 B2Stem Cell Reserve LP
- Artificial placenta and methods of preparation14 Jul 2026US 12,680,065 B2The Trustees of the University of Pennsylvania
- Perfused cell culturing systems and uses thereof8 Oct 2026US 2026/0308501 A1University of Delaware
- Methods and compositions for prenatal testing1 Oct 2026US 2026/0297511 A1EarlyCell, Inc.
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Immortalization of amnion-derived multipotent progenitor cell and uses thereof17 Sep 2026US 2026/0275276 A1Noveome Biotherapeutics, Inc.
- Methods of Genomic Evaluation in Livestock13 Aug 2026US 2026/0234721 A1Inguran, LLC
Most cited
By later US patents
- Primate embryonic stem cells641US 5,843,780 AWisconsin Alumni Research Foundation · 1998
- Primate embryonic stem cells497US 6,200,806 B1Wisconsin Alumni Research Foundation · 2001
- Tissue-derived tissuegenic implants, and methods of fabricating and using same329US 8,883,210 B1Musculoskeletal Transplant Foundation · 2014
- Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells185US 7,311,905 B2Anthrogenesis Corporation · 2007
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008